A prospective phase II trial exploring the association between tumor microenvironment biomarkers and clinical activity of ipilimumab in advanced melanoma
Omid Hamid, Henrik Schmidt, Aviram Nissan, Laura Ridolfi, Steinar Aamdal, Johan Hansson, Michele Guida, David M Hyams, Henry Gómez, Lars Bastholt, Scott D Chasalow, David BermanVolume:
9
Language:
english
DOI:
10.1186/1479-5876-9-204
Date:
December, 2011
File:
PDF, 529 KB
english, 2011